These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 11169832)

  • 21. Usefulness of controlled aliasing in parallel imaging results in higher acceleration in gadoxetic acid-enhanced liver magnetic resonance imaging to clarify the hepatic arterial phase.
    Park YS; Lee CH; Kim IS; Kiefer B; Woo ST; Kim KA; Park CM
    Invest Radiol; 2014 Mar; 49(3):183-8. PubMed ID: 24276676
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic accuracy of contrast-enhanced dynamic CT for small hypervascular hepatocellular carcinoma and assessment of dynamic enhancement patterns: Results of two-year follow-up using cone-beam CT hepatic arteriography.
    Choi YR; Chung JW; Yu MH; Lee M; Kim JH
    PLoS One; 2018; 13(9):e0203940. PubMed ID: 30231076
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CT versus MR imaging of hepatocellular carcinoma: toward improved treatment decisions.
    Murakami T; Okada M; Hyodo T
    Magn Reson Med Sci; 2012; 11(2):75-81. PubMed ID: 22790293
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dynamic contrast-enhanced ultrasound (DCE-US) for easy and rapid evaluation of hepatocellular carcinoma compared to dynamic contrast-enhanced computed tomography (DCE-CT)--a pilot study.
    Egger C; Goertz RS; Strobel D; Lell M; Neurath MF; Knieling F; Scharf M
    Ultraschall Med; 2012 Dec; 33(6):587-92. PubMed ID: 23154871
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differentiation of hypervascular hepatic pseudolesions from hepatocellular carcinoma: value of single-level dynamic CT during hepatic arteriography.
    Ueda K; Matsui O; Kawamori Y; Kadoya M; Yoshikawa J; Gabata T; Nonomura A; Takashima T
    J Comput Assist Tomogr; 1998; 22(5):703-8. PubMed ID: 9754101
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Optimal scan timing of hepatic arterial-phase imaging of hypervascular hepatocellular carcinoma determined by multiphasic fast CT imaging technique.
    Kagawa Y; Okada M; Yagyu Y; Kumano S; Kanematsu M; Kudo M; Murakami T
    Acta Radiol; 2013 Oct; 54(8):843-50. PubMed ID: 23761547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapy response assessment after radioembolization of patients with hepatocellular carcinoma--comparison of MR imaging with gadolinium ethoxybenzyl diethylenetriamine penta-acetic acid and gadobutrol.
    Schelhorn J; Best J; Reinboldt MP; Gerken G; Ruhlmann M; Lauenstein TC; Antoch G; Kinner S
    J Vasc Interv Radiol; 2015 Jul; 26(7):972-9. PubMed ID: 25937296
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease.
    Ichikawa T; Saito K; Yoshioka N; Tanimoto A; Gokan T; Takehara Y; Kamura T; Gabata T; Murakami T; Ito K; Hirohashi S; Nishie A; Saito Y; Onaya H; Kuwatsuru R; Morimoto A; Ueda K; Kurauchi M; Breuer J
    Invest Radiol; 2010 Mar; 45(3):133-41. PubMed ID: 20098330
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Double phase CT during hepatic arteriography for diagnosis of hepatocellular carcinoma.
    Murakami T; Takamura M; Kim T; Hori M; Federle MP; Onishi H; Tomoda K; Nakamura H
    Eur J Radiol; 2005 May; 54(2):246-52. PubMed ID: 15837405
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Superparamagnetic iron oxide-enhanced MR imaging for focal hepatic lesions: a comparison with CT during arterioportography plus CT during hepatic arteriography.
    Tanimoto A; Wakabayashi G; Shinmoto H; Nakatsuka S; Okuda S; Kuribayashi S
    J Gastroenterol; 2005 Apr; 40(4):371-80. PubMed ID: 15870974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of corona enhancement of hypervascular hepatocellular carcinoma by C-arm dual-phase cone-beam CT during hepatic arteriography.
    Miyayama S; Yamashiro M; Okuda M; Yoshie Y; Nakashima Y; Ikeno H; Orito N; Matsui O
    Cardiovasc Intervent Radiol; 2011 Feb; 34(1):81-6. PubMed ID: 20333382
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of hypervascular hepatocellular carcinoma with dynamic magnetic resonance imaging with simultaneously obtained in-phase and opposed-phase echo images.
    Sugihara E; Murakami T; Kim T; Hori M; Takamura M; Kawata S; Okada A; Khankan AA; Tomoda K; Nakamura H
    J Comput Assist Tomogr; 2003; 27(2):110-6. PubMed ID: 12702998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of hepatocellular carcinoma: combined T2-weighted and dynamic gadolinium-enhanced MRI versus combined CT during arterial portography and CT hepatic arteriography.
    Choi D; Kim SH; Lim JH; Cho JM; Lee WJ; Lee SJ; Lim HK
    J Comput Assist Tomogr; 2001; 25(5):777-85. PubMed ID: 11584240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preoperative evaluation of hepatocellular carcinoma: combined use of CT with arterial portography and hepatic arteriography.
    Kim HC; Kim TK; Sung KB; Yoon HK; Kim PN; Ha HK; Kim AY; Kim HJ; Lee MG
    AJR Am J Roentgenol; 2003 Jun; 180(6):1593-9. PubMed ID: 12760926
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic Significance of Concurrent Hypovascular and Hypervascular Nodules in Patients with Hepatocellular Carcinoma.
    Ogasawara S; Chiba T; Motoyama T; Kanogawa N; Saito T; Shinozaki Y; Suzuki E; Ooka Y; Tawada A; Kato H; Okabe S; Kanai F; Yoshikawa M; Yokosuka O
    PLoS One; 2016; 11(9):e0163119. PubMed ID: 27649084
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MR imaging of hypervascular liver tumors: timing optimization during the arterial phase.
    Van Beers BE; Materne R; Lacrosse M; Jamart J; Smith AM; Horsmans Y; Gigot JF; Gilon R; Pringot J
    J Magn Reson Imaging; 1999 Apr; 9(4):562-7. PubMed ID: 10232515
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of small hypervascular hepatocellular carcinomas by EASL criteria: comparison with double-phase CT during hepatic arteriography.
    Pugacheva O; Matsui O; Kozaka K; Minami T; Ryu Y; Koda W; Kobayashi S; Gabata T
    Eur J Radiol; 2011 Dec; 80(3):e201-6. PubMed ID: 20855175
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Triple arterial phase dynamic MRI with sensitivity encoding for hypervascular hepatocellular carcinoma: comparison of the diagnostic accuracy among the early, middle, late, and whole triple arterial phase imaging.
    Mori K; Yoshioka H; Takahashi N; Yamaguchi M; Ueno T; Yamaki T; Saida Y
    AJR Am J Roentgenol; 2005 Jan; 184(1):63-9. PubMed ID: 15615952
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-Hypervascular Hypointense Hepatic Nodules during the Hepatobiliary Phase of Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid-Enhanced MRI as a Risk Factor of Intrahepatic Distant Recurrence after Radiofrequency Ablation of Hepatocellular Carcinoma.
    Iwamoto T; Imai Y; Igura T; Kogita S; Sawai Y; Fukuda K; Yamaguchi Y; Matsumoto Y; Nakahara M; Morimoto O; Ohashi H; Fujita N; Kudo M; Takehara T
    Dig Dis; 2017; 35(6):574-582. PubMed ID: 29040990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hemodynamics of small hepatocellular carcinomas (5 cm or less in diameter): cases with discrepant findings between dynamic MR images and hepatic arteriograms.
    Imaeda T; Mochizuki R; Kanematsu M; Yamawaki Y; Goto H; Seki M; Doi H; Saji S; Shimokawa K
    Abdom Imaging; 1995; 20(6):534-40. PubMed ID: 8580749
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.